Salim Syed
Stock Analyst at Mizuho
(0)
# 4348
Out of 5,334 analysts
78
Total ratings
36.36%
Success rate
-12.05%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BIIB Biogen | Maintains: Outperform | 207 169 | 124.06 | 36.22% | 16 | May 7, 2025 | |
AMGN Amgen | Maintains: Neutral | 235 280 | 275.4 | 1.67% | 8 | May 7, 2025 | |
WVE WAVE Life Sciences | Maintains: Outperform | 19 22 | 6.69 | 228.85% | 5 | Nov 21, 2024 | |
NKTX Nkarta | Maintains: Outperform | 20 16 | 2.01 | 696.02% | 7 | Nov 21, 2024 | |
GILD Gilead Sciences | Maintains: Outperform | 90 100 | 103.89 | -3.74% | 6 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 99 103 | 32.32 | 218.69% | 6 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 113 163 | 31.75 | 413.39% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 25 18 | 7.14 | 152.1% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | 19.22 | 76.9% | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 82 99 | 37.81 | 161.84% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 53 | 35.79 | 48.09% | 7 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | 0.89 | 574.16% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 1.01 | 1979.21% | 5 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 168 36 | 12.34 | 191.73% | 1 | Nov 16, 2022 |